Earnings Date
EPS
Quarterly Revenue
Annual Revenue (as of Jun 30)
Earnings Recap
Immunome (NASDAQ:IMNM) reported its Q2 earnings results on Friday, August 5, 2022 at 07:30 AM.
Here's what investors need to know about the announcement.
Earnings
Immunome beat estimated earnings by 1.33%, reporting an EPS of $-0.74 versus an estimate of $-0.75.
Revenue was down $0 from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.27 which was followed by a 11.81% drop in the share price the next day.
Listen to the earnings announcement yourself by clicking here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Earnings History
Analyze the earnings history of Immunome using advanced sorting and filters.
Immunome Questions & Answers
Immunome (IMNM) is scheduled to report earnings on November 14, 2022. The last reported earnings were for reported on August 5, 2022 for Q2.
The Actual EPS was $-7.52, which missed the estimate of $0.00.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.